154 related articles for article (PubMed ID: 36048906)
1. Multicolor fluorescence activated cell sorting to generate humanized monoclonal antibody binding seven subtypes of BoNT/F.
Fan Y; Sun Z; Conrad F; Wen W; Zhao L; Lou J; Zhou Y; Farr-Jones S; Marks JD
PLoS One; 2022; 17(9):e0273512. PubMed ID: 36048906
[TBL] [Abstract][Full Text] [Related]
2. A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes.
Fan Y; Garcia-Rodriguez C; Lou J; Wen W; Conrad F; Zhai W; Smith TJ; Smith LA; Marks JD
PLoS One; 2017; 12(3):e0174187. PubMed ID: 28323873
[TBL] [Abstract][Full Text] [Related]
3. A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes.
Garcia-Rodriguez C; Razai A; Geren IN; Lou J; Conrad F; Wen WH; Farr-Jones S; Smith TJ; Brown JL; Skerry JC; Smith LA; Marks JD
Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29494481
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.
Garcia-Rodriguez C; Geren IN; Lou J; Conrad F; Forsyth C; Wen W; Chakraborti S; Zao H; Manzanarez G; Smith TJ; Brown J; Tepp WH; Liu N; Wijesuriya S; Tomic MT; Johnson EA; Smith LA; Marks JD
Protein Eng Des Sel; 2011 Mar; 24(3):321-31. PubMed ID: 21149386
[TBL] [Abstract][Full Text] [Related]
5. A Three-Monoclonal Antibody Combination Potently Neutralizes BoNT/G Toxin in Mice.
Fan Y; Lou J; Tam CC; Wen W; Conrad F; Leal da Silva Alves P; Cheng LW; Garcia-Rodriguez C; Farr-Jones S; Marks JD
Toxins (Basel); 2023 Apr; 15(5):. PubMed ID: 37235351
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
Sharma R; Zhao H; Al-Saleem FH; Ubaid AS; Puligedda RD; Segan AT; Lindorfer MA; Bermudez R; Elias M; Adekar SP; Simpson LL; Taylor RP; Dessain SK
Mol Immunol; 2014 Feb; 57(2):247-54. PubMed ID: 24184879
[TBL] [Abstract][Full Text] [Related]
7. A Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D.
Garcia-Rodriguez C; Yan S; Geren IN; Knopp KA; Dong J; Sun Z; Lou J; Conrad F; Wen WH; Farr-Jones S; Smith TJ; Brown JL; Skerry JC; Smith LA; Marks JD
Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564645
[TBL] [Abstract][Full Text] [Related]
8. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
Fan Y; Barash JR; Lou J; Conrad F; Marks JD; Arnon SS
J Infect Dis; 2016 May; 213(10):1606-14. PubMed ID: 26936913
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity.
Fan Y; Geren IN; Dong J; Lou J; Wen W; Conrad F; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
PLoS One; 2015; 10(8):e0135306. PubMed ID: 26275214
[TBL] [Abstract][Full Text] [Related]
10. The Novel Clostridial Neurotoxin Produced by Strain IBCA10-7060 Is Immunologically Equivalent to BoNT/HA.
Fan Y; Barash JR; Conrad F; Lou J; Tam C; Cheng LW; Arnon SS; Marks JD
Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31877649
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B.
Fan Y; Dong J; Lou J; Wen W; Conrad F; Geren IN; Garcia-Rodriguez C; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
Toxins (Basel); 2015 Aug; 7(9):3405-23. PubMed ID: 26343720
[TBL] [Abstract][Full Text] [Related]
12. Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS.
Kalb SR; Garcia-Rodriguez C; Lou J; Baudys J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR
PLoS One; 2010 Aug; 5(8):e12237. PubMed ID: 20808925
[TBL] [Abstract][Full Text] [Related]
13. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.
Smith TJ; Lou J; Geren IN; Forsyth CM; Tsai R; Laporte SL; Tepp WH; Bradshaw M; Johnson EA; Smith LA; Marks JD
Infect Immun; 2005 Sep; 73(9):5450-7. PubMed ID: 16113261
[TBL] [Abstract][Full Text] [Related]
14. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
Levy R; Forsyth CM; LaPorte SL; Geren IN; Smith LA; Marks JD
J Mol Biol; 2007 Jan; 365(1):196-210. PubMed ID: 17059824
[TBL] [Abstract][Full Text] [Related]
15. Production of serotype C specific and serotype C/D generic monoclonal antibodies using recombinant H(C) and H(N) fragments from Clostridium botulinum neurotoxin types C(1) and D.
Curran RM; Fringuelli E; Graham D; Elliott CT
Vet Immunol Immunopathol; 2009 Jul; 130(1-2):1-10. PubMed ID: 19233482
[TBL] [Abstract][Full Text] [Related]
16. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin.
Garcia-Rodriguez C; Levy R; Arndt JW; Forsyth CM; Razai A; Lou J; Geren I; Stevens RC; Marks JD
Nat Biotechnol; 2007 Jan; 25(1):107-16. PubMed ID: 17173035
[TBL] [Abstract][Full Text] [Related]
17. Botulinum Neurotoxin F Subtypes Cleaving the VAMP-2 Q
Sikorra S; Skiba M; Dorner MB; Weisemann J; Weil M; Valdezate S; Davletov B; Rummel A; Dorner BG; Binz T
Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30071628
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a neutralizing monoclonal antibody against botulinum neurotoxin serotype F, following vaccination with active toxin.
Brown DR; Lloyd JP; Schmidt JJ
Hybridoma; 1997 Oct; 16(5):447-56. PubMed ID: 9388028
[TBL] [Abstract][Full Text] [Related]
19. Expression and biochemical characterization of light chains of Botulinum neurotoxin subtypes F5 and F7.
Guo J; Chen S
Protein Expr Purif; 2015 Jul; 111():87-90. PubMed ID: 25858313
[TBL] [Abstract][Full Text] [Related]
20. Development and partial characterization of high-affinity monoclonal antibodies for botulinum toxin type A and their use in analysis of milk by sandwich ELISA.
Stanker LH; Merrill P; Scotcher MC; Cheng LW
J Immunol Methods; 2008 Jul; 336(1):1-8. PubMed ID: 18452945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
